BXLT: Baxalta Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 35,862.51
Book Value ($M) 4,220.00
Book Value / Share 6.17
Price / Book 7.45
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.33
Current Ratio 2.47

Balance Sheet (mrq) ($M)
Current Assets 4,876.00
Assets 12,824.00
Liabilities 8,604.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6,148.00
Operating Income n/a
Net Income 956.00
Earnings Per Share Diluted 1.40
Earnings Per Share Basic 1.41

Cash Flow Statement (mra) ($M)
Cash From Operations 799.00
Cash from Investing -2,293.00
Cash from Financing -2,293.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2016-06-07 13G Integrated Core Strategies (us) Llc 0.00
2016-05-27 13G/A Baxter International Inc 0.00 -100.00
2016-02-09 13G BlackRock Inc. 5.70 2,259.69
2016-02-08 13G/A JP Morgan Chase & Co 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
ALR – Alere Inc. BHS – Bausch Health Companies
BMY – Bristol-Myers Squibb Co. CBM – Cambrex Corp.
CTLT – Catalent Inc.


Financial data and stock pages provided by
Fintel.io